Perioperative Management of Diabetes Mellitus: Novel Approaches
- 130 Downloads
Purpose of Review
Several studies have demonstrated the benefits of glycemic control in the perioperative period and there is ongoing interest in development of systematic approaches to achieving glycemic control. This review discusses currently available data and proposes a new approach to the management of hyperglycemia in the perioperative period.
In a recent study, we demonstrated that early preoperative identification of patients with poorly controlled diabetes and proactive treatment through various phases of surgery improves glycemic control, lowers the risk of surgical complications, and decreases the length of hospital stay.
Implementation of a perioperative diabetes program that systematically identifies and treats patients with poor glycemic control early in the preoperative period is feasible and improves clinical care of patients undergoing elective surgery.
KeywordsDiabetes mellitus Hyperglycemia Surgery outcomes Perioperative treatment Stress hyperglycemia
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest. Many studies performed by the authors are cited in the text.
Human and Animal Right and Informed Consent
This is a review article and it did not involve conducting studies with humans or animals.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplast. 2010;25(1):64–70. https://doi.org/10.1016/j.arth.2008.10.002.CrossRefGoogle Scholar
- 5.Buehler L, Fayfman M, Alexopoulos AS, Zhao L, Farrokhi F, Weaver J, et al. The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients. J Diabetes Complicat. 2015;29(8):1177–82. https://doi.org/10.1016/j.jdiacomp.2015.07.027.CrossRefPubMedGoogle Scholar
- 12.Dandona P, Aljada A, Dhindsa S, Garg R. Insulin as an anti-inflammatory and antiatherosclerotic hormone. Clin Cornerstone. 2003;Suppl 4:S13–20. https://doi.org/10.1016/S1098-3597(03)90062-7.
- 14.Dandona P, Aljada A, Chaudhuri A, Mohanty P. Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord. 2004;5(3):189–97. https://doi.org/10.1023/B:REMD.0000032407.88070.0a.CrossRefPubMedGoogle Scholar
- 17.Ramos M, Khalpey Z, Lipsitz S, Steinberg J, Panizales MT, Zinner M, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg. 2008;248(4):585–91. https://doi.org/10.1097/SLA.0b013e31818990d1.CrossRefPubMedGoogle Scholar
- 19.• Sathya B, Davis R, Taveira T, Whitlatch H, Wu WC. Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2013;102(1):8–15. https://doi.org/10.1016/j.diabres.2013.05.003. This study highlights the correlation of glucose levels with postoperative outcomes and suggests perioperative glycemic targets. CrossRefPubMedGoogle Scholar
- 22.Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109(12):1497–502. https://doi.org/10.1161/01.CIR.0000121747.71054.79.CrossRefPubMedGoogle Scholar
- 25.Offodile AC II, Chou HY, Lin JA, Loh CYY, Chang KP, Aycart MA, et al. Hyperglycemia and risk of adverse outcomes following microvascular reconstruction of oncologic head and neck defects. Oral Oncol. 2018;79:15–9. https://doi.org/10.1016/j.oraloncology.2018.02.009.CrossRefPubMedGoogle Scholar
- 28.• Underwood P, Askari R, Hurwitz S, Chamarthi B, Garg R. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37(3):611–6. https://doi.org/10.2337/dc13-1929. This study shows that HbA1c > 8% is associated with long hospital stay in patients undergoing a non-cardiac surgery. Therefore, HbA1c 8% is a good threshold for glycemic control before surgery.
- 29.O’Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006;32(2):188–97. https://doi.org/10.1016/j.ejvs.2006.01.011.CrossRefPubMedGoogle Scholar
- 30.Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Kerendi F, Song HK, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008;136(3):631–40. https://doi.org/10.1016/j.jtcvs.2008.02.091.CrossRefPubMedGoogle Scholar
- 32.Jehan F, Khan M, Sakran JV, Khreiss M, O’Keeffe T, Chi A, et al. Perioperative glycemic control and postoperative complications in patients undergoing emergency general surgery: what is the role of plasma hemoglobin A1c? J Trauma Acute Care Surg. 2018;84(1):112–7. https://doi.org/10.1097/TA.0000000000001724.CrossRefPubMedGoogle Scholar
- 33.Yang L, Sun Y, Li G, Liu J. Is hemoglobin A1c and perioperative hyperglycemia predictive of periprosthetic joint infection following total joint arthroplasty?: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(51):e8805. https://doi.org/10.1097/MD.0000000000008805.CrossRefGoogle Scholar
- 34.Steely AM, Smith L, Callas PW, Nathan MH, Lahiri JE, Stanley AC, et al. Prospective study of postoperative glycemic control with a standardized insulin infusion protocol after infrainguinal bypass and open abdominal aortic aneurysm repair. Ann Vasc Surg. 2017. https://doi.org/10.1016/j.avsg.2017.04.020.
- 35.Lamos EM, Wijesinha MA, Ramhmdani S, Magder LS, Silver KD. Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation. Diabetes Metab Syndr Obes. 2017;10:13–7. https://doi.org/10.2147/DMSO.S118437.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.•• Dhatariya K, Levy N, Kilvert A, Watson B, Cousins D, Flanagan D, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29(4):420–33. https://doi.org/10.1111/j.1464-5491.2012.03582.x. This paper is British guidelines for the perioperative management of diabetes. CrossRefPubMedGoogle Scholar
- 39.•• Underwood P, Seiden J, Carbone K, Chamarthi B, Turchin A, Bader AM, et al. Early identification of individuals with poorly controlled diabetes undergoing elective surgery: improving A1C testing in the preoperative period. Endocr Pract. 2015;21(3):231–6. https://doi.org/10.4158/EP14228.OR. This study describes the process of implementation of a preoperative program for HbA1c testing and the outcomes of this program. CrossRefPubMedGoogle Scholar
- 41.• Garg R, Metzger C, Rein R, Lortie M, Underwood P, Hurwitz S, et al. Nurse practitioner-mediated intervention for preoperative control of diabetes in elective surgery patients. J Am Assoc Nurse Pract. 2016;28(10):528–33. https://doi.org/10.1002/2327-6924.12365. This study showed that non-physician providers can improve the implementation of a perioperative diabetes program. CrossRefPubMedGoogle Scholar
- 42.•• Garg R, Schuman B, Bader A, Hurwitz S, Turchin A, Underwood P, et al. Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery. Ann Surg. 2018;267(5):858–62. https://doi.org/10.1097/SLA.0000000000002323. This study showed that a systematic identification of patients with poorly controlled diabetes and their proactive treatment can improve glycemic control and decrease length of hospital stay. CrossRefPubMedGoogle Scholar
- 44.Rushakoff RJ, Wick EC, McDonnell ME. Enhanced recovery in patients with diabetes: is it time for a moratorium on use of preoperative carbohydrate beverages? Ann Surg. 2018. https://doi.org/10.1097/sla.0000000000002989.
- 46.American Diabetes Association. Diabetes care in the hospital. Diabetes Care. 2016;39(Supplement 1):S99–S104. https://doi.org/10.2337/dc16-S016.
- 48.Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61. https://doi.org/10.2337/dc10-1407.CrossRefPubMedPubMedCentralGoogle Scholar
- 50.Fayfman M, Davis G, Duggan EW, Urrutia M, Chachkhiani D, Schindler J, et al. Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: a pilot randomized study. J Diabetes Complicat. 2018;32:1091–6. https://doi.org/10.1016/j.jdiacomp.2018.08.014.CrossRefPubMedGoogle Scholar
- 51.Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diab Endocrinol. 2017;5(2):125–33. https://doi.org/10.1016/s2213-8587(16)30402-8.CrossRefGoogle Scholar